跳至主要内容
临床试验/PACTR201508001191898
PACTR201508001191898已完成未知

Validation of New Biomarkers for Monitoring Plasmodium falciparum Reduced susceptibility/Tolerance or Resistance to Artemisinin Derivatives and Partner Drugs in Nigeria.

EDCTP0 个研究点目标入组 0 人开始时间: 2015年7月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Month(s) 至 15 Year(s)(—)
性别
All

入选标准

  • Symptoms compatible with acute uncomplicated malaria with pure Plasmodium falciparum parasitemia.
  • Microscopically confirmed P. falciparum infection with parasite density ¿ 2,000/¿l of blood
  • Body (axillary) temperature > 37.4oC or history of fever 24 ¿ 48 hours preceding presentation.
  • No have other concomitant illness.
  • No history of antimalarial use in the two weeks preceding presentation.
  • Ability and willingness to comply with the protocol for the duration of the study and to comply with the study visit schedule.
  • Written informed consent given by parents or guardians.

排除标准

  • Severe malaria
  • Severe malnutrition.
  • Serious underlying disease (renal, cardiac, hepatic)
  • Concomitant febrile illness.
  • Known allergy to study drug or its components.

研究者

发起方
EDCTP

相似试验